433 related articles for article (PubMed ID: 26797588)
1. Indoxyl sulfate, not p-cresyl sulfate, is associated with cognitive impairment in early-stage chronic kidney disease.
Yeh YC; Huang MF; Liang SS; Hwang SJ; Tsai JC; Liu TL; Wu PH; Yang YH; Kuo KC; Kuo MC; Chen CS
Neurotoxicology; 2016 Mar; 53():148-152. PubMed ID: 26797588
[TBL] [Abstract][Full Text] [Related]
2. Meta-Analysis of the Associations of p-Cresyl Sulfate (PCS) and Indoxyl Sulfate (IS) with Cardiovascular Events and All-Cause Mortality in Patients with Chronic Renal Failure.
Lin CJ; Wu V; Wu PC; Wu CJ
PLoS One; 2015; 10(7):e0132589. PubMed ID: 26173073
[TBL] [Abstract][Full Text] [Related]
3. Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120.
Liu WC; Tomino Y; Lu KC
Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30208594
[TBL] [Abstract][Full Text] [Related]
4. The relationship of indoxyl sulfate and p-cresyl sulfate with target cardiovascular proteins in hemodialysis patients.
Wu PH; Lin YT; Chiu YW; Baldanzi G; Huang JC; Liang SS; Lee SC; Chen SC; Hsu YL; Kuo MC; Hwang SJ
Sci Rep; 2021 Feb; 11(1):3786. PubMed ID: 33589722
[TBL] [Abstract][Full Text] [Related]
5. The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
Bennis Y; Cluet Y; Titeca-Beauport D; El Esper N; Ureña P; Bodeau S; Combe C; Dussol B; Fouque D; Choukroun G; Liabeuf S
Toxins (Basel); 2019 May; 11(5):. PubMed ID: 31109001
[TBL] [Abstract][Full Text] [Related]
6. Protein-bound uremic toxins, inflammation and oxidative stress: a cross-sectional study in stage 3-4 chronic kidney disease.
Rossi M; Campbell KL; Johnson DW; Stanton T; Vesey DA; Coombes JS; Weston KS; Hawley CM; McWhinney BC; Ungerer JP; Isbel N
Arch Med Res; 2014 May; 45(4):309-17. PubMed ID: 24751327
[TBL] [Abstract][Full Text] [Related]
7. LC-MS/MS method for simultaneous determination of serum p-cresyl sulfate and indoxyl sulfate in patients undergoing peritoneal dialysis.
Shu C; Chen X; Xia T; Zhang F; Gao S; Chen W
Biomed Chromatogr; 2016 Nov; 30(11):1782-1788. PubMed ID: 27129599
[TBL] [Abstract][Full Text] [Related]
8. Uraemic toxins and cardiovascular disease across the chronic kidney disease spectrum: an observational study.
Rossi M; Campbell K; Johnson D; Stanton T; Pascoe E; Hawley C; Dimeski G; McWhinney B; Ungerer J; Isbel N
Nutr Metab Cardiovasc Dis; 2014 Sep; 24(9):1035-42. PubMed ID: 24880738
[TBL] [Abstract][Full Text] [Related]
9. Measuring serum total and free indoxyl sulfate and p-cresyl sulfate in chronic kidney disease using UPLC-MS/MS.
Lin CN; Wu IW; Huang YF; Peng SY; Huang YC; Ning HC
J Food Drug Anal; 2019 Apr; 27(2):502-509. PubMed ID: 30987721
[TBL] [Abstract][Full Text] [Related]
10. The fecal microbiome and serum concentrations of indoxyl sulfate and p-cresol sulfate in cats with chronic kidney disease.
Summers SC; Quimby JM; Isaiah A; Suchodolski JS; Lunghofer PJ; Gustafson DL
J Vet Intern Med; 2019 Mar; 33(2):662-669. PubMed ID: 30561098
[TBL] [Abstract][Full Text] [Related]
11. Dietary protein-fiber ratio associates with circulating levels of indoxyl sulfate and p-cresyl sulfate in chronic kidney disease patients.
Rossi M; Johnson DW; Xu H; Carrero JJ; Pascoe E; French C; Campbell KL
Nutr Metab Cardiovasc Dis; 2015 Sep; 25(9):860-865. PubMed ID: 26026209
[TBL] [Abstract][Full Text] [Related]
12. Serum indoxyl sulfate concentrations associate with progression of chronic kidney disease in children.
Holle J; Kirchner M; Okun J; Bayazit AK; Obrycki L; Canpolat N; Bulut IK; Azukaitis K; Duzova A; Ranchin B; Shroff R; Candan C; Oh J; Klaus G; Lugani F; Gimpel C; Büscher R; Yilmaz A; Baskin E; Erdogan H; Zaloszyc A; Özcelik G; Drozdz D; Jankauskiene A; Nobili F; Melk A; Querfeld U; Schaefer F;
PLoS One; 2020; 15(10):e0240446. PubMed ID: 33108385
[TBL] [Abstract][Full Text] [Related]
13. Protein-bound uremic toxin lowering strategies in chronic kidney disease: a systematic review and meta-analysis.
Takkavatakarn K; Wuttiputinun T; Phannajit J; Praditpornsilpa K; Eiam-Ong S; Susantitaphong P
J Nephrol; 2021 Dec; 34(6):1805-1817. PubMed ID: 33484425
[TBL] [Abstract][Full Text] [Related]
14. Evolution of protein-bound uremic toxins indoxyl sulphate and p-cresyl sulphate in acute kidney injury.
Veldeman L; Vanmassenhove J; Van Biesen W; Massy ZA; Liabeuf S; Glorieux G; Vanholder R
Int Urol Nephrol; 2019 Feb; 51(2):293-302. PubMed ID: 30604232
[TBL] [Abstract][Full Text] [Related]
15. The Role of Liver in Determining Serum Colon-Derived Uremic Solutes.
Lin CJ; Liou TC; Pan CF; Wu PC; Sun FJ; Liu HL; Chen HH; Wu CJ
PLoS One; 2015; 10(8):e0134590. PubMed ID: 26258409
[TBL] [Abstract][Full Text] [Related]
16. Renal clearance and intestinal generation of p-cresyl sulfate and indoxyl sulfate in CKD.
Poesen R; Viaene L; Verbeke K; Claes K; Bammens B; Sprangers B; Naesens M; Vanrenterghem Y; Kuypers D; Evenepoel P; Meijers B
Clin J Am Soc Nephrol; 2013 Sep; 8(9):1508-14. PubMed ID: 23813557
[TBL] [Abstract][Full Text] [Related]
17. Indoxyl sulfate associates with cardiovascular phenotype in children with chronic kidney disease.
Holle J; Querfeld U; Kirchner M; Anninos A; Okun J; Thurn-Valsassina D; Bayazit A; Niemirska A; Canpolat N; Bulut IK; Duzova A; Anarat A; Shroff R; Bilginer Y; Caliskan S; Candan C; Harambat J; Özcakar ZB; Soylemezoglu O; Tschumi S; Habbig S; Yilmaz E; Balat A; Zurowska A; Cakar N; Kranz B; Ertan P; Melk A; Azukaitis K; Schaefer F
Pediatr Nephrol; 2019 Dec; 34(12):2571-2582. PubMed ID: 31428929
[TBL] [Abstract][Full Text] [Related]
18. The specific impact of uremic toxins upon cognitive domains: a review.
Franco ÁO; Starosta RT; Roriz-Cruz M
J Bras Nefrol; 2019; 41(1):103-111. PubMed ID: 30095142
[TBL] [Abstract][Full Text] [Related]
19. Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): A Randomized Trial.
Rossi M; Johnson DW; Morrison M; Pascoe EM; Coombes JS; Forbes JM; Szeto CC; McWhinney BC; Ungerer JP; Campbell KL
Clin J Am Soc Nephrol; 2016 Feb; 11(2):223-31. PubMed ID: 26772193
[TBL] [Abstract][Full Text] [Related]
20. Indoxyl sulfate, not P-cresyl sulfate, is associated with advanced glycation end products in patients on long-term hemodialysis.
Lin CJ; Lin J; Pan CF; Chuang CK; Liu HL; Sun FJ; Wang TJ; Chen HH; Wu CJ
Kidney Blood Press Res; 2015; 40(2):121-9. PubMed ID: 25833743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]